Sercan Bulut ÇELİK, Hüseyin CAN, MELİH KAAN SÖZMEN, Tijen ŞENGEZER, YUSUF CEM KAPLAN, Alp ŞENER, Arzu AYBEK YILMAZ, Olgu AYGÜN

Evaluation of the neuropathic pain in the smokers

Amaç: Nikotin bağımlılığı sigara içme davranışının sürdürülmesinde ve tedavi girişimlerinin genel başarısızlığında en önemli nedenlerdendir. Periferik nöropatide, sigara kullanımı, önde gelen risk etkenlerindendir. Çalışmamızda sigara içen bireylerin bağımlılık düzeyi ile nöropatik ağrı açısından birlikteliğinin incelenmesi amaçlanmıştır.Gereç ve Yöntem: Araştırma herhangi bir nedenle hastaneye gelmiş olan sigara içicileri üzerinde 1 günlük sürede yapıldı. Douleur Neuropathique 4 (DN-4) Anketi, Fagerström Bağımlılık Anketi kişilerin onamı alındıktan sonra yüz yüze görüşülerek uygulandı. Veri çözümlemede, ki kare testi ve çok değişkenli lojistik regresyon analizinden yararlanıldı. Regresyon analizi sonucunda elde edilen Olasılıklar oranları (OR) %95 güven aralıkları ile sunuldu. Anlamlılık düzeyi olarak p

Sigara kullanıcılarında nöropatik ağrının değerlendirilmesi

Objectives: Nicotine addiction is one of the most important causes of the general failure of treatment and keeping the habit of smoking. Peripheral neuropathy is a leading factor of smoking. This study aimed to analyze the association of neuropathic pain and addiction levels of individuals.Methods: The study was performed on the day on which the smokers visited the hospital for any reason. The Douleur Neuropathique 4 (DN-4) Scale and Fagerström Addiction Survey were administered to the individuals after obtaining their consent.Results: In total, 444 individuals were included in the study, and 57.2% of them were males (n = 254). The age average of the individuals with neuropathic pain (46.4±12.3 years) was significantly higher than that of those without pain. The individuals with pain smoked approximately 31.8±18.3 packet/year cigarettes, whereas those without pain smoked approximately 22.4 ± 15.5 packet/year cigarettes; the difference was significant statistically (p

PDF

___

Okutan O, Taş D, Kaya H, Kartaloğlu Z. Affecting factors of nicotine dependence in the smoker health workers. Tu- berk Toraks 2007;55(4):356–63.
Richardson JK, Ho S, Wolf J, Spiegelberg T. The nature of the relationship between smoking and ulnar neuropathy at the elbow. Am J Phys Med Rehabil 2009;88(9):711–8.
Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associa- ted with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114(1-2):29–36.
Unal-Cevik I, Sarioglu-Ay S, Evcik D. A comparison of the DN4 and LANSS questionnaires in the assessment of neu- ropathic pain: validity and reliability of the Turkish version of DN4. J Pain 2010;11(11):1129–35.
Fagerstrom KO, Schneider NG. Measuring nicotine depen- dence: a review of the Fagerstrom Tolerance Questionnai- re. J Behav Med 1989;12(2):159–82.
Uysal MA, Kadakal F, Karşidağ C, Bayram NG, Uysal O, Yil- maz V. Fagerstrom test for nicotine dependence: reliabi- lity in a Turkish sample and factor analysis. Tuberk Toraks 2004;52(2):115–21.
Little MA, Ebbert JO. The safety of treatments for tobacco use disorder. Expert Opin Drug Saf 2016;15(3):333–41.
Oncel C, Baser S, Cam M, Akdağ B, Taspinar B, Evyapan F. Peripheral neuropathy in chronic obstructive pulmonary disease. COPD 2010;7(1):11–6.
Kayacan O, Beder S, Deda G, Karnak D. Neurophysiological changes in COPD patients with chronic respiratory insuffi- ciency. Acta Neurol Belg 2001;101(3):160–5.
Gupta PP, Sood S, Atreja A, Agarwal D. Evaluation of bra- in stem auditory evoked potentials in stable patients with chronic obstructive pulmonary disease. Ann Thorac Med 2008;3(4):128–34.
Clair C, Cohen MJ, Eichler F, Selby KJ, Rigotti NA. The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis. J Gen Intern Med 2015;30(8):1193–203.
Papanas N, Ziegler D. Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015. Rev Diabet Stud 2015;12(1-2):48–62.
Tamer A, Yildiz S, Yildiz N, Kanat M, Gunduz H, Tahtaci M, et al. The prevalence of neuropathy and relationship with risk factors in diabetic patients: a single-center experience. Med Princ Pract 2006;15(3):190–4.
Thomas E. Preventing amputation in adults with diabetes: identifying the risks. Nurs Stand 2015;29(40):49–58.
Fushimi H, Inoue T, Yamada Y, Matsuyama Y, Kameyama M. Profound vasoconstrictive effect of cigarette smoking in diabetics with autonomic neuropathy. Diabetes Res Clin Pract 1992;16(3):191–5.
Barnouin J, Peŕez Cristiá R, Chassagne M, Barrios TV, Ar- naud J, Fleites Mestre P, et al. Vitamin and nutritional sta- tus in Cuban smokers and nonsmokers in the context of an emerging epidemic neuropathy. Int J Vitam Nutr Res 2000;70(3):126–38.
Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv Ophthalmol 1998;42(6):535–47.
Newman NJ. Leber hereditary optic neuropathy: bad ha- bits, bad vision? Brain 2009;132(Pt 9):2306–8.
Pourmemari MH, Viikari-Juntura E, Shiri R. Smoking and carpal tunnel syndrome: a meta-analysis. Muscle Nerve 2014;49(3):345–50.
Poza JJ, Cobo AM, Martí-Massó JF. Neuropathy associated with arteriosclerosis. Rev Neurol 1997;25(144):1194–7.
Rojewski AM, Baldassarri S, Cooperman NA, Gritz ER, Leone FT, Piper ME, et al. Exploring Issues of Comorbid Conditions in People Who Smoke. Nicotine Tob Res 2016;18(8):1684–96.
Benbow SJ, Williams G, MacFarlane IA. Smoking habits and painful diabetic neuropathy. J Diabetes Complications 1997;11(6):334–7.